Depression News and Research

Latest Depression News and Research

Non-pharmaceutical help should be offered for pain, fatigue, anxiety at the time of MS diagnosis

Two recently published studies by UW Medicine researchers indicate that clinicians should offer non-pharmaceutical help for pain, fatigue, depression, or anxiety at the time of diagnosis for patients with multiple sclerosis, rather than wait.

30 May 2022

Investigating post-COVID complaints after Delta versus Omicron variant infections

A new study discusses whether infection with the SARS-CoV-2 Omicron variant increases the risk of post-COVID complaints Delta infection.

30 May 2022

Medical cannabis use shown to improve cancer-related symptoms in new study

Researchers describe the effectiveness and safety of medical cannabis use for treating cancer-related symptoms.

30 May 2022

Increase in depression and anxiety rates in the U.K. identified during COVID-19 lockdowns

Researchers discuss changes in depressive and anxiety symptoms during the COVID-19 pandemic.

30 May 2022

Neurological symptoms may persist for over one year in long-COVID patients

Patients who have recovered from COVID-19 are likely to experience persistent neurologic symptoms for a median of 14.8 months following their initial infection.

30 May 2022

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

A new study utilizes multisystem imaging, along with biomarker analysis, to better understand the pathogenesis of COVID-19.

30 May 2022

Analysis of social media posts reveals how people learned to cope with the pandemic

Researchers who analyzed language related to depression on social media during the pandemic say the data suggest people learned to cope as the waves wore on.

27 May 2022

Autistic adults have worse health and poorer quality healthcare

Autistic individuals are more likely to have chronic mental and physical health conditions, suggests new research from the University of Cambridge. Autistic individuals also report lower quality healthcare than others.

27 May 2022

The frequency, nature, determinants, and impact of long-COVID in Scotland

Researchers evaluated long-term sequelae of COVID-19 in Scotland.

26 May 2022

Ketamine uses a previously unknown pathway to produce an antidepressant effect, study finds

For the 280 million people suffering from depression globally, relief cannot come fast enough. Monoaminergic antidepressants, including selective serotonin reuptake inhibitors (SSRIs) take weeks to months to take effect and do not work for more than one in three patients.

26 May 2022

RED-D intervention reduces unplanned hospital readmissions for individuals with depressive symptoms

Results from a new study at Boston Medical Center show how transition support and post-discharge depression treatment reduce unplanned hospital readmissions for individuals with depressive symptoms.

25 May 2022

Correlation between long-COVID and physical inactivity

In a recent study under review at the Scientific Reports journal and posted to the Research Square* preprint server, researchers assessed whether physical inactivity in coronavirus disease 2019 (COVID-19) survivors led to the development of post-acute sequelae of COVID-19 (PASC), also known as long-COVID.

25 May 2022

The interaction between genetics and the impact of the COVID-19 pandemic on individuals’ wellbeing over time

The study examined how genetics affected the physical and mental health and behavioral patterns related to lifestyle, using data from the Lifelines biobank.

23 May 2022

Adventurous play may help prevent mental health problems in children

Children who spend more time playing adventurously have lower symptoms of anxiety and depression, and were happier over the first Covid-19 lockdown, according to new research.

20 May 2022

Novel brain-permeable Cdk5 inhibitor alters neurobehavior in mice

James Bibb, Ph.D., and colleagues have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.

20 May 2022

Medicinal cannabis can be considered as alternative to pain relief medicines for cancer patients

A comprehensive assessment of the benefits of medical cannabis for cancer-related pain found that for most oncology patients, pain measures improved significantly, other cancer-related symptoms also decreased, the consumption of painkillers was reduced, and the side effects were minimal.

20 May 2022

Psychological risk factors may increase chances of hospitalization after COVID-19 diagnosis

People who reported in a survey that they felt worried, depressed or lonely had a greater chance of being hospitalized after a COVID-19 diagnosis, suggests a study funded by the National Institutes of Health.

19 May 2022

Video song in times of COVID-19 served to alleviate collective traumatic experience

In February 2020, a group of musicians from around the world living in China recorded their cover of a song by Michael Jackson on video to express their support to the families affected by the COVID-19 pandemic and to those working in the frontline.

19 May 2022

Brief embrace with a romantic partner may subsequently reduce stress-induced cortisol response

Women instructed to embrace their romantic partner prior to undergoing a stressful experience had a lower biological stress response-;as indicated by levels of the stress hormone cortisol in saliva-;compared to women who did not embrace their partner.

18 May 2022

Do people experience more anxiety, depression and distress after COVID?

A recent study posted to the medRxiv* preprint server analyzed mental health outcomes after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

18 May 2022

Depression News and Research

Latest Depression News and Research

Non-pharmaceutical help should be offered for pain, fatigue, anxiety at the time of MS diagnosis

Investigating post-COVID complaints after Delta versus Omicron variant infections

Medical cannabis use shown to improve cancer-related symptoms in new study

Increase in depression and anxiety rates in the U.K. identified during COVID-19 lockdowns

Neurological symptoms may persist for over one year in long-COVID patients

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

Analysis of social media posts reveals how people learned to cope with the pandemic

Autistic adults have worse health and poorer quality healthcare

The frequency, nature, determinants, and impact of long-COVID in Scotland

Ketamine uses a previously unknown pathway to produce an antidepressant effect, study finds

RED-D intervention reduces unplanned hospital readmissions for individuals with depressive symptoms

Correlation between long-COVID and physical inactivity

The interaction between genetics and the impact of the COVID-19 pandemic on individuals’ wellbeing over time

Adventurous play may help prevent mental health problems in children

Novel brain-permeable Cdk5 inhibitor alters neurobehavior in mice

Medicinal cannabis can be considered as alternative to pain relief medicines for cancer patients

Psychological risk factors may increase chances of hospitalization after COVID-19 diagnosis

Video song in times of COVID-19 served to alleviate collective traumatic experience

Brief embrace with a romantic partner may subsequently reduce stress-induced cortisol response

Do people experience more anxiety, depression and distress after COVID?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in